Date: 2011-07-21
Type of information: Production agreement
Compound: viral protein complex using the rePAX™ technology
Company: Redbiotech (Switzerland) undisclosed pharmaceutical company
Therapeutic area:
Type agreement: manufacturing
production
supply
Action mechanism:
Disease:
Details: Redbiotec has entered into a perennial collaboration agreement with an undisclosed large pharmaceutical company. Under the contract, Redbiotec will manufacture and re-supply a relevant viral protein complex using the rePAX™ technology.
Financial terms:
Latest news:
